Register Log-in Investor Type

In the press

‘The drama may not be over yet’: Apollo-backed offer could spark bidding war for Hipgnosis Songs

Biotech trusts top performance charts in February

Valeria Martinez, Investment Week, 18 April 2024:

Hipgnosis Songs Fund’s (SONG) share price has soared by nearly a third on the back of a $1.4bn deal to acquire the trust, with potential for the offer to spark a bidding war.

After enduring months of turmoil, investors in the £1.6bn music royalties trust are hoping the Apollo-backed deal proposed by Concord Chorus finally puts an end to the saga.

The cash offer values each Hipgnosis share at $1.16, or 93p, a 32% premium to its closing price on Wednesday (17 April), and 2.8% above the recent Shot Tower valuation report..

James Carthew, head of investment company research at QuotedData, said it is possible the deal could kick-start a bidding war, while manager Hipgnosis Song Management may find a way to exercise its pre-emption right to buy the portfolio at the same price.

“The drama may not be over yet but it does feel like we are in the final Act,” he said.

Read more here

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…